What Is the Medicare Part D Coverage Gap?
A prescription that cost very little in January can suddenly feel a lot more expensive by midyear, and it’s not because the pharmacy changed anything — it’s because the person’s drug plan quietly moved into a different phase.
The short answer
The Part D coverage gap, sometimes called the “donut hole,” is a phase in Medicare’s prescription drug benefit that some enrollees move into after their combined drug costs for the year reach a certain point. During this phase, the enrollee’s share of drug costs has historically differed from the earlier phase of the year, before shifting again once total spending crosses a further threshold into catastrophic coverage. The specific cost-sharing percentages and dollar thresholds are set by government rules and change over time, so the useful thing to understand is the structure, not any single year’s numbers.
How the phases generally work
Part D coverage isn’t a single flat cost-sharing arrangement for the whole year — it’s structured in phases that a person moves through as their total drug spending accumulates. Early in the year, enrollees typically pay a defined share of drug costs under initial coverage. As spending adds up, some plans and drug types move the enrollee into the coverage gap phase, and eventually, once spending is high enough, into a catastrophic phase where cost-sharing changes again. Movement between phases is based on cumulative spending, not the calendar, so someone with high drug costs early in the year can reach later phases faster than someone with more modest, steady costs.
Why the gap surprises people
Because the early part of the year often feels manageable, the shift into the coverage gap phase can catch people off guard, especially if they’re managing multiple prescriptions or a single high-cost medication. It’s also easy to assume that once a plan’s deductible is met, cost-sharing stays constant for the rest of the year — but Part D’s phased structure means that’s often not the case. Understanding this ahead of time is part of what makes choosing a plan with a favorable rating more than just a matter of comparing premiums.
What to weigh when comparing plans
Because different plans handle formularies, tiers, and phase transitions differently, the “cheapest” plan by premium alone isn’t always the cheapest plan across a full year of actual drug costs. Someone taking a small number of low-cost generic medications may barely notice phase transitions, while someone on multiple brand-name drugs may move through the phases much faster. This is one of several reasons that people delaying or coordinating Part D enrollment benefit from actually estimating their expected annual drug costs rather than guessing.
The connection to staying enrolled
The coverage gap concept is also relevant to people thinking about whether to delay Part D enrollment in the first place, since going without what’s considered creditable prescription drug coverage for too long can lead to a lasting premium increase down the road, independent of how the coverage-gap phase itself works in any given year.
The takeaway
The Part D coverage gap isn’t a one-time cliff — it’s a phase within a broader, cumulative structure that shifts cost-sharing as spending adds up over the year. Because the specific thresholds and percentages are adjusted by government rules over time, the more durable habit is understanding how the phases relate to each other and reviewing plan details annually, rather than assuming this year’s numbers will hold steady indefinitely.